Matthew W. Johnson

Dr. Matthew Johnson, a leading researcher in psychedelic medicine, dives deep into the transformative potential of substances like psilocybin and MDMA. He discusses their ability to alter perception and self-identity, potentially providing lasting relief from depression and trauma when administered in clinical settings. The conversation touches on the promising role of psychedelics in neurological recovery and the fascinating world of microdosing. Johnson also highlights the importance of therapeutic environments and prepares us for understanding the profound impacts of these substances on mental health.

Matthew W. Johnson, Ph.D., a world-renowned researcher in psychedelics, discusses his studies on psilocybin for smoking cessation and cancer distress treatment. He shares the initial findings of psilocybin vs. nicotine patch as smoking cessation treatments. The podcast also highlights the significance of funding therapeutic studies and the transformative power of psychedelic medicine in personal growth and evolution. The role of researchers and advisors in the psychedelic ecosystem, the concept of perennial philosophy, and the importance of finding qualified providers and integration in psychedelic research are also explored.